Author: WTN News

Columnist Michael Rosen does some Bio-MidAmerican Investor Conference follow up and looks at a recent report ranking the climate for start-up businesses in 178 countries. In this edition of Yer Biotech Blues, he notes that the United States and other major developed nations rank lower...

Globalization briskly marches on - one step ahead of our ability to measure and understand its effects. Economists, corporate leaders, and government officials trumpet the benefits of globalization but few have called attention to the risks for countries, companies, and individuals, opines Tony DiRomualdo. ...

Global companies are discovering Wisconsin's many business benefits, as Microsoft's recent acquisition of Jellyfish.com clearly demonstrates, according to Inside Wisconsin columnist Tom Still. Microsoft, however, is only the latest corporate giant to "Discover Wisconsin" and its business merits, which speaks volumes about Wisconsin's ability...

WiMAX will be a big alternative to big cities, especially after the “free” Wi-Fi business model has fizzled, observes James Carlini, and that's one of several impressions from the recent WiMAX WORLD Conference in Chicago. In this edition of Carlini's Comments, he said the conference...

Cellectar, which designs and develops products to detect, treat, and monitor human cancers, has named Ernest Allen as director of clinical operations and Lisa Ann Trembath as manager of medical affairs. The appointments come as Cellectar moves its lead drug candidate toward clinical trials....

To prevent future IT implementation failures in state government agencies, the man in charge of information technology for the state of Wisconsin has spelled out new processes for the annual strategic plans of state agencies and planning standards for large, high-risk IT projects. Oskar Anderson,...

The Wisconsin Alumni Research Foundation has filed amendments with the U.S. Patent and Trademark Office to make technical changes to the claims of its three human embryonic stem cell patents. WARF said the technical language submitted to PTO examiners more clearly differentiates the University of...

TomoTherapy executives prefer investors to take the long view of their financial performance, but the company's projected third quarter performance is nothing to scoff at. The Madison based medical device manufacturer has revised its third quarter projections, which indicate a 61 percent increase in anticipated...